How much funding has Amigo raised?

Amigo has raised $17.3M in total funding, most recently a series a round.

Who are Amigo's investors?

Amigo's investors include General Catalyst, GSV Ventures, Comma Capital, CohoVC.

Where is Amigo headquartered?

Amigo is headquartered in New York, New York, United States.

What industry is Amigo in?

Amigo operates in Artificial Intelligence, Healthcare.

Amigo

The trusted platform for clinical agents

New York, United States · Founded 2024 · $17.3M raised

Artificial Intelligence

Healthcare

Headquarters: New York, New York
Employees: 11–50
Founded: 2024
Business Model: B2B

Website: amigo.ai
Total Funding: $17.3M
Last Round: $11.0M Series AMar 2026
Rounds: 2

About

Amigo is a clinical AI infrastructure platform that helps healthcare organizations build, train, and deploy patient-facing AI agents. Its proprietary Digital Residency program trains every agent against millions of simulated patient cases until they achieve a 100% clinical safety pass rate. Amigo integrates with all major EHRs and supports use cases from intake and triage to chronic care management and 24/7 virtual care.

Summary

Amigo is an Artificial Intelligence company based in New York, United States, founded in 2024. It has raised $17.3M in total across 2 rounds, most recently a $11.0M Series A round in Mar 2026. Investors include General Catalyst, GSV Ventures and Comma Capital.